Literature DB >> 11266234

Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma.

G Cheng1, T Ueda, K Sugiyama, M Toda, T Fukuda.   

Abstract

Recent studies have found that severe surfactant dysfunction occurs during an asthma attack, but the changes in surfactant in a guinea-pig model of chronic asthma have not been studied. We therefore analysed the surfactant recovered from guinea-pigs after repeated inhalation of ovalbumin to see if the surfactant recovered from chronic asthmatic lungs would be intrinsically altered. Guinea pigs immunized through repeated inhalation of aerosolized ovalbumin (OA) were exposed to the antigen once a week for a month. Twenty-four hours after the last challenge the alveolar wash was recovered. We calculated saturated phosphatidylcholine (Sat-PC) and total protein (TP) pool sizes in alveolar spaces. Surfactant subtype conversion of large aggregate surfactant (LA) to small aggregate surfactant was studied in vitro by means of the surface area cycling technique. The phospholipid composition of LA was analysed by thin layer chromatography and the surface activity of LA was also determined. We found decreased surfactant pool sizes, decreased ratio of Sat-PC to TP in alveolar lavages in asthma groups, and surface activity of the surfactant recovered from asthmatic lungs to be inferior to that of the controls. Accelerated surfactant subtype conversion in vitro was also noted in the lungs of asthmatic animal models. In addition, the changes in phospholipid compositions which were similar to the pattern of acute lung injury suggested that alveolar inflammation might be involved in the pathogenesis of chronic asthma. These results indicate that surfactant is intrinsically abnormal in chronically asthmatic lungs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266234     DOI: 10.1053/rmed.2000.1012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

Review 1.  Biomechanics of liquid-epithelium interactions in pulmonary airways.

Authors:  Samir N Ghadiali; Donald P Gaver
Journal:  Respir Physiol Neurobiol       Date:  2008-04-22       Impact factor: 1.931

Review 2.  Lung surfactant in subacute pulmonary disease.

Authors:  Gehan Devendra; Roger G Spragg
Journal:  Respir Res       Date:  2002-04-04

3.  Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma.

Authors:  Tamer Y El Mays; Parichita Choudhury; Richard Leigh; Emmanuel Koumoundouros; Joanne Van der Velden; Grishma Shrestha; Cora A Pieron; John H Dennis; Francis Hy Green; Ken J Snibson
Journal:  Respir Res       Date:  2014-09-16

4.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

5.  Interferon-alpha inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model [corrected].

Authors:  Yasuko Kikkawa; Kumiya Sugiyama; Kazuki Obara; Hirokuni Hirata; Yasutsugu Fukushima; Masao Toda; Takeshi Fukuda
Journal:  Asia Pac Allergy       Date:  2012-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.